Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Memantine Treatment Report
What is Memantine?

Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system. It is also being tested for use as a cognitive enhancer in a variety of other conditions. Read more...Click to read more below

Merz's Memantine site

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 25%
None
3 75%

Most commonly reported side effects

Metallic taste in mouth
1 25%
  • Mild
  • Moderate
  • Severe

Dosages

  5 mg daily 10 mg daily 15 mg daily 20 mg daily 200 mg daily
  4 Number of Patients: 4 4 Number of Patients: 4 2 Number of Patients: 2 13 Number of Patients: 13 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Memantine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Personal research
1 100% Personal research: 100%

See all 1 patient who’ve stopped taking Memantine

Duration See details about how long patients take this treatment ▼

Currently Taking Memantine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
5
3
6

Stopped Taking Memantine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
4 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 25%
Not at all
3 75%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
2 50%
< $25
1 25%

Report created on November 21, 2009.